Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for OCTREOTIDE

Ingredient

OCTREOTIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOSTATIN	100MCG	SOLUTION	Actual shortage	2024-02-06	2024-03-21	218624
SANDOSTATIN	50MCG	SOLUTION	Actual shortage	2024-03-22	2024-10-01	223074
SANDOSTATIN LAR	30MG	POWDER FOR SUSPENSION, SUSTAINED-RELEASE	Resolved	2026-02-10	2026-03-05	277784
SANDOSTATIN LAR	30MG	POWDER FOR SUSPENSION, SUSTAINED-RELEASE	Resolved	2025-04-03	2025-08-06	254013
SANDOSTATIN LAR	20MG	POWDER FOR SUSPENSION, SUSTAINED-RELEASE	Resolved	2025-04-03	2025-08-06	254019
SANDOSTATIN LAR	10MG	POWDER FOR SUSPENSION, SUSTAINED-RELEASE	Resolved	2025-07-14	2025-11-04	262673

Previous
1
2
3
4

Showing 31 to 36 of 36

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
OCPHYL	500MCG	SOLUTION	Reversed	2017-04-10	2017-04-10	6237
SANDOSTATIN	100MCG	SOLUTION	Discontinued	2024-03-22	2024-03-22	223070
SANDOSTATIN	200MCG	SOLUTION	Discontinued	2022-02-08	2022-03-07	154429

1

Showing 1 to 3 of 3